Collegium Pharmaceutical, Inc (COLL): EPS (Diluted)
$1.73
Year ended 2025-12-31
+17.9%
5-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.73 | -7.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $1.86 | +44.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $1.29 | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$0.74 | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $1.86 | +144.7% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $0.76 | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$0.68 | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$1.19 | n/a | 2021-02-25, From 2018-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.73 | -7.0% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $0.82 | -33.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $0.93 | n/m |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | -$0.01 | n/m |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $0.16 | n/m |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $2.03 | -33.7% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | -$0.68 | n/m |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $2.71 | +8.0% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $3.32 | n/m |
Compare COLL, CORT, EBS, ARWR side by side · Screen every company in Pharmaceutical Preparations ↗